2016
DOI: 10.3389/fped.2016.00055
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers in Pediatric ARDS: Future Directions

Abstract: Acute respiratory distress syndrome (ARDS) is common among mechanically ventilated children and accompanies up to 30% of all pediatric intensive care unit deaths. Though ARDS diagnosis is based on clinical criteria, biological markers of acute lung damage have been extensively studied in adults and children. Biomarkers of inflammation, alveolar epithelial and capillary endothelial disruption, disordered coagulation, and associated derangements measured in the circulation and other body fluids, such as bronchoa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 193 publications
(199 reference statements)
0
19
0
Order By: Relevance
“…A rapidly progressive area of research is in understanding the role of biomarkers not only in the diagnosis and prognosis of ARDS, but also in potential therapeutic options to alter such biomarkers (91). Inflammatory proteins in the matrix metalloproteinase (MMP) family have been shown to be elevated in pediatric ALI (92) with a specific increase in MMP-9 production in RSV infection.…”
Section: Pathophysiology and Histology Of Rsv And Influenza A (H1n1) mentioning
confidence: 99%
“…A rapidly progressive area of research is in understanding the role of biomarkers not only in the diagnosis and prognosis of ARDS, but also in potential therapeutic options to alter such biomarkers (91). Inflammatory proteins in the matrix metalloproteinase (MMP) family have been shown to be elevated in pediatric ALI (92) with a specific increase in MMP-9 production in RSV infection.…”
Section: Pathophysiology and Histology Of Rsv And Influenza A (H1n1) mentioning
confidence: 99%
“…Several studies have shown that altered innate responses and hypercytokinemia in patients with ARDS developed from H5N1, H7N9, and SARS‐CoV infection . Several inflammatory mediators were reported to be biomarkers of ARDS and potential predictors of poor outcome . However, few studies have examined the inflammatory response, specifically in severe ARDS of pulmonary origin in children with respiratory virus infections.…”
Section: Introductionmentioning
confidence: 99%
“… 31 Sepsis generally initiates a systemic inflammatory response, and proinflammatory cytokines, such as tumor necrosis factor alpha, interleukin 1 beta (IL-1β), IL-6, and IL-8, 32 , 33 are released. These cytokines activate neutrophils to produce toxic mediators and damage the endothelium and alveolar epithelium, 34 36 eventually leading to alveolar–capillary barrier injury. 30 , 37 Then, the protein-rich fluid induces acute pulmonary edema and inactivates PS.…”
Section: Discussionmentioning
confidence: 99%